Source:http://linkedlifedata.com/resource/pubmed/id/15069697
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2004-4-7
|
pubmed:abstractText |
5-aminolevulinic acid (ALA)-induced protoporphyrin IX (PPIX) fluorescence has shown an outstanding sensitivity for the assessment of oral lesions, but its application was hampered by low specificity due to the high false-positive rates. The purpose of our study was to explore the feasibility of quantifying PPIX fluorescence images to improve the diagnostic specificity for detecting early oral lesions in vivo. A digitized 5-ALA-mediated endoscopic imaging system was utilized to acquire PPIX fluorescence images from in vivo oral tissues. Forty-nine patients (118 biopsies) with known or suspected premalignant or malignant oral lesions were recruited for ALA-PPIX fluorescence endoscopic imaging. The red and blue channels of PPIX fluorescence images were digitized and stored for fluorescence quantification. The red-to-blue intensity ratios were calculated from the fluorescence images to correlate with histologic findings of the biopsies. The results showed that normal oral mucosa exhibited blue color of the back-scattered excitation light in the fluorescence images, whereas the suspicious lesions displayed bright reddish fluorescence. Applying the red-to-blue intensity ratio (I(R)/I(B)) as a diagnostic algorithm yielded a sensitivity of 92% and 98%, and specificity of 96% and 96%, for separating benign tissue from dysplasia, and cancer tissue, respectively, and a sensitivity and specificity of 98% and 92%, respectively, for differentiating cancer tissue from dysplasia in the oral cavity. Our study demonstrates that quantifying ALA-PPIX fluorescence endoscopic images associated with the red-to-blue intensity ratio as a diagnostic algorithm can provide good differentiation between the different stages of oral premalignancy and malignancy (p<0.0001, unpaired 2-sided Student's t-test), and thus has a potential to significantly improve the noninvasive diagnosis and evaluation of early oral neoplasia in vivo.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0020-7136
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright 2004 Wiley-Liss, Inc.
|
pubmed:issnType |
Print
|
pubmed:day |
10
|
pubmed:volume |
110
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
295-300
|
pubmed:dateRevised |
2007-7-24
|
pubmed:meshHeading |
pubmed-meshheading:15069697-Adult,
pubmed-meshheading:15069697-Aged,
pubmed-meshheading:15069697-Aged, 80 and over,
pubmed-meshheading:15069697-Aminolevulinic Acid,
pubmed-meshheading:15069697-Diagnostic Imaging,
pubmed-meshheading:15069697-Endoscopy,
pubmed-meshheading:15069697-Female,
pubmed-meshheading:15069697-Fluorescence,
pubmed-meshheading:15069697-Humans,
pubmed-meshheading:15069697-Male,
pubmed-meshheading:15069697-Middle Aged,
pubmed-meshheading:15069697-Mouth Neoplasms,
pubmed-meshheading:15069697-Precancerous Conditions,
pubmed-meshheading:15069697-Protoporphyrins,
pubmed-meshheading:15069697-Sensitivity and Specificity
|
pubmed:year |
2004
|
pubmed:articleTitle |
The use of digitized endoscopic imaging of 5-ALA-induced PPIX fluorescence to detect and diagnose oral premalignant and malignant lesions in vivo.
|
pubmed:affiliation |
Division of Medical Sciences, National Cancer Centre, Singapore. dmszhw@nccs.com.sg
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|